Eli Lilly Canada Revenue and Competitors

CAN

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Eli Lilly Canada's estimated annual revenue is currently $42.6M per year.(i)
  • Eli Lilly Canada's estimated revenue per employee is $201,000

Employee Data

  • Eli Lilly Canada has 212 Employees.(i)
  • Eli Lilly Canada grew their employee count by 4% last year.

Eli Lilly Canada's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.8M34-41%N/AN/A
#2
$88M4389%N/AN/A
#3
$86.8M43224%N/AN/A
#4
$53.1M2640%N/AN/A
#5
$1.2M60%N/AN/A
#6
$14.3M716%N/AN/A
#7
$43.8M2186%N/AN/A
#8
$2.2M110%N/AN/A
#9
$23.3M1166%N/AN/A
#10
$36.2M18031%N/AN/A
Add Company

What Is Eli Lilly Canada?

Lilly makes medicines that help people live longer, healthier, more active lives. Founded in 1938, Eli Lilly Canada built its first facility in 1946 and the Canadian headquarters are still located on this site in Toronto, Ontario. Today, the company employs approximately 450 people across the country in our pharmaceutical division. Eli Lilly Canada has been recognized as one of the 50 Most Engaged Workplacesâ„¢ in Canada. The annual award recognizes top employers that display leadership and innovation in engaging employees. Generations of Lilly employees have sustained a culture that values excellence, integrity and respect for people. Globally, Eli Lilly and Company employs approximately 41,000 people and markets medicines in 120 countries. With major Research and Development facilities in six countries and clinical research conducted in more than 55 countries, Lilly’s work continues to break new ground, placing it on the leading edge in many of today’s most important areas of health care research.

keywords:N/A

N/A

Total Funding

212

Number of Employees

$42.6M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Eli Lilly Canada News

2022-04-20 - People with diabetes and cognitive decline may be at higher ...

... suggest cognitive function could predict a person's future risk of heart disease. The study received funding from Eli Lilly and Company.

2022-04-13 - JARDIANCE® (empagliflozin) becomes the first and only ...

BURLINGTON, ON and TORONTO, April 12, 2022 /CNW/ - Health Canada has ... Boehringer Ingelheim (Canada) Ltd. and Eli Lilly Canada Inc. have...

2022-03-30 - Novo Nordisk snags high-dose Ozempic approval, turning up ...

Novo Nordisk's Ozempic, grappling with Eli Lilly's Trulicity for supremacy of the ... injectable is already approved in the EU, Canada and Switzerland.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$39.6M2122%N/A
#2
$42M212N/AN/A
#3
$42M212N/AN/A
#4
$15M2125%N/A
#5
$63M2128%N/A